Executive Committee

Sunil Bhilotra

Managing Director and interim Chief Executive Officer

MBA, London Business School

Bachelor of Commerce, McGill University

Professional background

Sunil Bhilotra served as Director of Portfolio Management, Healthcare, Pharma and Life Sciences at ADQ since 2020. He has been a Board member of Acino Group since 2022.


Gary Hughes

Chief Financial Officer

Honours Degree in Law of Leeds University, UK

Professional background

  • 2017-18

    Interim Chief Financial Officer at Solifos AG in Windisch, Switzerland

  • 2016-17

    Chief Financial Officer at Equatex AG in Zurich, Switzerland

  • 2013-16

    Chief Financial Officer at Selecta Management AG in Cham, Switzerland

  • 2008-13

    Group Financial Controller at Selecta Management AG in Cham, Switzerland

  • 2004-08

    Head of Financial Reporting and Accounting at Ciba Vision AG in Embrach, Switzerland

  • 2001-04

    Senior Manager, Assurance Services at Ernst & Young in Manchester, UK and Zurich, Switzerland

  • 1999-01

    Financial Reporting Lecturer at Accountancy Tuition Centres in Manchester, UK

  • 1994-99

    Supervisor Assurance Services at Ernst & Young in Manchester, UK


Sarah Egan

Chief Human Resources Officer

EMCCC Organizational Behavior Studies, INSEAD

Bachelor’s degree in Social Sciences, University of Leicester

Professional background

  • 2016-19

    VP of HR, Region Europe, Roche

  • 2015-16

    Global Head of HR, Quality, Novartis

  • 2012-15

    Head of Talent Management and Organisational Development; Asia Pacific, Middle East, Africa, Novartis

  • 2011-12

    Senior HR Business Partner Asia Pacific, Middle East and African Countries, Novartis

  • 2010-11

    Head of Talent Management and Organisational Development, Northern Europe, Novartis

  • 2006-10

    Global Human Resources Business Partner, Novartis


Mario Ricard

Chief Operations Officer

Master of Business Administration and Bachelor of Science – Mechanical Engineering from the University of Sherbrooke in Canada.

Professional background

  • 2015-17

    Vice President – Plasma Manufacturing Europe at Baxalta/Shire, Zurich

  • 2014-15

    Vice President – Operations Strategy at Baxter, Zurich

  • 2012-14

    Vice President – Technical Services and BioSurgery Manufacturing at Baxter, Belgium and Switzerland

  • 2010-12

    Operations Director at Baxter, Belgium

  • 2003-10

    Plant Manager at Baxter, Belgium

  • 1999-03

    Plant Manager at Baxter, Canada

  • 1992-99

    Various roles in Production, Purchasing and Planning at Baxter, Canada


Laura Galimberti

Global Head of Commercial Operations

MBA SDA Bocconi

Master Degree in Telecommunication Engineering

Professional background

  • 2015-17

    Global Head of Commercial Excellence, Boehringer Ingelheim Animal Health in Germany

  • 2011-15

    Italy Office Manager, ZS Associates in Italy

  • 2008-09

    Business Consulting Manager, Cap Gemini in Italy

  • 2005-08

    Senior Consultant, Ernst & Young in France

  • 2003-05

    Business Consultant, Accenture in Italy


Andrew Bird

Head of Middle East, Turkey and Africa

MBA, Cranfield School of Management, Cranfield

PhD in Organic Chemistry, University of York, York

BSc (Hons) Chemistry, University of East Anglia, Norwich

Professional background

  • 2017-18

    General Manager Gulf, Eastern Mediterranean & Maghreb Region, Dubai

  • 2011-17

    Strategy & Operations Director Middle East, Africa & India

  • 2016-17

    General Manager Maghreb Region at Bristol-Myers Squibb

  • 2013-14

    General Manager South Africa at Bristol-Myers Squibb

  • 2011-11

    Business Director at Pase II Gulf, Dubai

  • 2009-10

    Regional Marketing Director Africa & Middle East (AfME)

  • 2008-09

    Senior European brand Manager at Pfizer

  • 1999-07

    Sales & Marketing roles at Janssen-Cilag Ltd. Uk & Ireland

  • 1997-98

    Medicinal Chemist at Cerebrus Ltd.

  • 1996-97

    Research Chemist at Glaxowellcome

  • 1995-96

    Production Manager at Croda International


Eugene Zaika

Head of Ukraine and CIS

DBA degree (ongoing), International Management Institute (IMI-Kyiv)

MBA, International Management Institute (IMI-Kyiv)

PhD in cardiology, Research Institute of Therapy (Academy of Medical Science of Ukraine)

MD, Kharkiv Medical Institute, honors

Professional background

  • 2011-15

    Takeda Cluster Head for Ukraine, Belarus, Moldova and Israel / General Director LLC Takeda Ukraine

  • 2008-11

    General Director, LLC Nycomed Ukraine

  • 2005-08

    Head of Represenative office of Nycomed in Ukraine and Moldova

  • 2005-05

    Marketing Manager, Sanofi-Aventis Ukraine and Moldova

  • 2000-04

    Marketing Manager, Aventis Intercontinental (Ukraine)

  • 1998-00

    East Ukraine Area Manager, Rhone-Poulenc Rorer (Ukraine)

  • 1994-97

    Medical representative, Rhone-Poulenc Rorer (Ukraine)

  • 1993-97

    Cardiologist, scientific associate in the department of clinical pharmacology, Research Institute of Therapy (Kharkiv)


Steve Mahoney

Head of New Regions (Africa, Latin America and Russia)

M.B.A, Rutgers Business School, New Jersey

B.A., Business Administration, Rutgers University, New Jersey

Professional background

  • 2017-19

    Vice President, Head of MetAsia Region, Boehringer-Ingelheim (formerly Merial)

  • 2014-16

    Vice President, Head of Asia Region, Merial Asia

  • 2013-15

    Head of Large Animals, Merial US

  • 2008-13

    Chief Information Officer, Merial

  • 2005-08

    Head of Global Supply Chain and Procurement, Merial

  • 2001-05

    Head of Companion Animals Enterprise, Asia Pacific and Latin America Regions, Merial

  • 2000-01

    Senior Director of Global E-business, Merial

  • 1997-00

    Associate Director, Business Administration, Merial Australia


Global Leadership Team (GLT)

Christina Peusch

Chief Legal & Integrity and Compliance Officer

German qualified lawyer, University of Passau, Passau, Germany

Professional background

  • 2013-15

    Head of Legal EUCAN (Europe/Canada), Emerging Markets and North Asia, Takeda Pharmaceuticals International GmbH, Zurich

  • 2012-13

    Senior Director Corporate Legal Affairs, Takeda Pharmaceuticals International GmbH, Zurich

  • 2010-12

    Senior Director International Legal Affairs, Nycomed Germany Holding GmbH, Konstanz, Germany

  • 2007-09

    Director International Legal Affairs, Nycomed Germany Holding GmbH, Konstanz, Germany

  • 2004-07

    International Legal Affairs Manager, Altana Pharma AG, Konstanz, Germany

  • 1995-04

    Clifford Chance (prev. Pünder, Volhard, Weber & Axster), member of the Commercial Law and Corporate Finance practice areas and (chief) representative of the Beijing office; Frankfurt am Main and Munich, Germany, and Beijing, PRC.


Eva Kopecna

Global Head of Regulatory Affairs, Medical Affairs and Pharmacovigilance

MD University of Palacky, CZ

MSc in Regulatory Affairs University of Wales, UK

PhD in Clinical and Social Pharmacy Charles University, CZ

Professional background

  • 2019-20

    Head of Regulatory Affairs, Zentiva, Prague

  • 2012-18

    Senior Director Regulatory Affairs Global OTC, PGT Healthcare, Geneva

  • 2004-12

    Regulatory Affairs Director, Teva Pharmaceuticals, Opava, Czech Republic


Larisa Bernstein

Global Head of Communications

Larisa holds a degree from the University of Oslo, Norway, where she majored in English and marketing communications.

 

Professional background

  • 2020-21

    Senior Communications Leader, Global Neuroscience and Rare Diseases DTA, Hoffmann-La Roche, Switzerland

  • 2018-20

    Communications Leader, Global Medical Affairs, Takeda Pharmaceuticals, Switzerland

  • 2010-18

    Marketing and Communications Manager, Landis+Gyr, Switzerland

  • 2006-09

    Senior Corporate Communications Manager, Nycomed (now Takeda Pharmaceuticals), Denmark & Switzerland

  • 2000-06

    PR and Communications Manager, Nycomed Russia/CIS (now Takeda Pharmaceuticals), Russia


Khatira Mansouri

Global Head of Quality

Khatira is a trained pharmacist from Ruprecht-Karls-University – Heidelberg, Germany, and a European Qualified Person.

Professional background

  • 2016-20

    Head of External Quality Biologics Drug Product, Drug Substance & Medical Devices, Novartis, Switzerland

  • 2015-15

    Social business projects in Afghanistan

  • 2013-14

    Head of Quality Assurance - Quality Release Complaint Management, Novartis Vaccines and Diagnostics, Germany

  • 2012-13

    Head of Quality Management Third Party, Novartis, Germany

  • 2011-12

    Production Manager, Sandoz, USA

  • 2009-11

    Quality Assurance Compliance Manager, Novartis, Switzerland

  • 2010-10

    Nomination for Novartis Accelerated Quality Management Development Program (AQMD), Novartis, Switzerland

  • 2006-09

    Manager Quality Assurance & European Qualified Person, Novartis, Germany


Philippe Seminati

Global Head of Supply Chain

Master’s Degree in Mechanical Engineering – University of Metz, France.

Professional background

  • 2016-18

    Freelance Supply Chain Consultant, accross Europe

  • 2012-16

    Director Corporate Supply Chain, Aenova Group, Germany

  • 2010-12

    Senior Supply Chain Consultant, BeOne Group, Switzerland

  • 2010-10

    Freelance Supply Chain Consultant, GSK, Belgium

  • 2009-10

    Freelance Supply Chain Consultant, across Europe

  • 2008-09

    Head of Supply Chain – Johnson Control Automotive, Germany

  • 2002-08

    Logistics, Supplier & Parts Manager – Smart France SAS (Daimler Group), France


Ralph Halter

Global Head of IT

BSc Marketing, University of Applied Science FHNW Basel

Professional background

  • 2009-19

    Corporate Head of IT Strategy and Planning, Panalpina, Basel

  • 2003-05

    Head of IT Competence Center Latin America, Panalpina, Brazil

  • 1995-03

    Head of Corporate Data Center, Panalpina Basel

  • 1993-95

    Senior Data Administrator Retail, Ikea, Southern Europe, Basel

  • 1990-92

    Product Manager, Fides Informatik, Basel


John Norman

Head of the Africa Region

Bachelor of Commerce Majored in Marketing & Economics

Professional background

  • 2017-18

    General Manager Litha Healthcare, South Africa

  • 2014-17

    Managing Director Africa at Takeda

  • 2007-14

    CEO Takeda South Africa, Sub Saharan Africa & Indian Ocean Islands

  • 1999-08

    Marketing & Sales Director Janssen- Cilag Pharmaceuticals, South Africa

  • 1998-99

    Business Unit Manager Janssen-Cilag Consumer Pharmaceuticals, South Africa

  • 1993-98

    Regional Sales Manager Jannsen-Cilag Pharmaceuticals, South Africa

  • 1991-93

    Product Manager Adcock Ingram Pharmaceuticals, South Africa

  • 1988-91

    Product Manager J&J Medical, South Africa

  • 1987-88

    Professional Sales Representative J&J Medical, South Africa


Denis Glyadyaev

Head of Russia

The Russian State Social University. Finance

Professional background

  • 2017-18

    OTC Business Unit Director Russia at Akrikhin/Polpharma, Moscow

  • 2015-17

    Sales and Business Development Director Russia and Belarus at Kimberly-Clark, Moscow

  • 2013-15

    Regional Director of Caucasus countries at Kimberly-Clark, Baku

  • 2010-13

    Head of Marketing for Baby Child Care and Family Care at Kimberly-Clark, Moscow

  • 2008-13

    Head of Trade Marketing for Family Care & Baby Child Care businesses at Kimberly-Clark, Moscow

  • 2006-08

    Regional Trade Marketing Leader Russia and CIS at Dirol Cadbury LLC, Moscow

  • 2004-06

    Head of Trade Marketing at EFKO Foods, Russia

  • 1998-04

    Various roles in sales in Russian companies

  • 1997-98

    Credit Expert at 'SBS - AGRO' Bank, Moscow


Jim Harold

Head of the Latin America Region (LATAM)

Bachelor of Science in Physiology from the University of Newcastle Upon Tyne

 

 

Professional background

  • 2015-19

    President and Head of Middle East and North Africa, Novartis Pharma Services AG

  • 2011-15

    Head of Novartis Vaccines Latin America, Novartis Argentina

  • 2003-11

    CEO and Country President, Novartis Argentina

  • 2001-03

    VP Transplant and Immunology Business Unit, Novartis USA

  • 2000-01

    CEO and Country President, Novartis Chile

  • 1998-99

    Head of Sales and Marketing Region Americas, Novartis Brazil

  • 1997-98

    Head of Specialty Business Unit, Novartis Argentina

  • 1994-96

    Head of Sales and Marketing Argentina, Sandoz

  • 1991-94

    General Manager West Africa, Sandoz


Board of Directors

Fahad Al Qassim

Chairman of the Board of Acino Group since April 2022

MBA in Finance, Monash University in Melbourne, Australia

Bachelor in Applied Computing, Leeds Metropolitan University in the UK

Professional background

Fahad Al Qassim is the Executive Director of Healthcare, Pharma and Financial Services at ADQ. He also serves as the Chairman of the Board of Amoun Pharmaceuticals and a Board Member of Pure Health, Daman, SEHA and Aramex. Prior to joining ADQ, Fahad served as the CEO of Emirates NBD Capital.


Kaj-Erik Relander

Vice Chairman of the Board and Chair of the Audit Committee of Acino Group since July 2022

MBA, Aalto University in Finland and the Wharton School in the USA

MSc in Economics, Aalto University in Finland

Professional background

Kaj-Erik Relander is a businessman and an investor. In 2019, he joined ADQ as Member of the Board and Audit and Executive Committees. Kaj-Erik serves as a board member at a number of other companies, including Abu Dhabi Global Markets, Louis Dreyfus Company, SES (SESG), Starzplay Arabia and Apis Partners Private Equity Fund.


Sunil Bhilotra

Member of the Board of Acino Group since April 2022

MBA, London Business School

Bachelor of Commerce, McGill University

Professional background

Sunil Bhilotra served as Director of Portfolio Management, Healthcare, Pharma and Life Sciences at ADQ since 2020.


Per Edelmann

Member of the Board of Acino Group since July 2022

MSc, MBA and Bachelor in Finance from the Copenhagen Business School in Denmark

Professional background

Per Edelmann is an independent life sciences advisor and founder of Edelmann Advisory. Since 2014, he has served as an Operating Partner at Apax Partners and member of multiple non-executive boards in Europe, Middle East and North Africa.


Wael Al Hashimi

Member of the Board of Acino Group since July 2022

MBA in International Business, American Intercontinental University London, United Kingdom

Bachelor of Science in Mathematics and Business Management, Queen Mary University in the UK

Board membership and executive mandates within the Acino Group

Wael Al Hashimi has served as the Associate Director, Alternative Investments and M&A at ADQ in the UAE since 2018. Prior to joining ADQ, he served as a Principal – Private Equity at Alcazar Capital in Dubai, UAE. Wael Al Hashimi holds board memberships at ADS Holding in the UAE, and Alexandria Container and Cargo Handling Company in Egypt.


Louay Abou Chanab

Member of the Board of Acino Group since July 2022

MBA in International Business, American Intercontinental University London, United Kingdom

Bachelor of Science in Mathematics and Business Management, Queen Mary University in the UK

Professional background

Wael Al Hashimi has served as the Associate Director, Alternative Investments and M&A at ADQ in the UAE since 2018. Prior to joining ADQ, he served as a Principal – Private Equity at Alcazar Capital in Dubai, UAE. Wael Al Hashimi holds board memberships at ADS Holding in the UAE, and Alexandria Container and Cargo Handling Company in Egypt.